483
Aurobindo Pharma LtdAurobindo Pharma Ltd – FDA 483, Jul 21, 2023
Record Details
An FDA inspection of Aurobindo Pharma Ltd in Medchal, Telangana, revealed three significant observations. These included a lack of validated equipment cleaning procedures, poor facility maintenance with a leaking ceiling in the quality control laboratory, and a failure to follow established laboratory control mechanisms, evidenced by contaminated test media. These issues indicate deficiencies in the firm's manufacturing and quality control processes.
View Company Profile
ID · 33feb8af-e76c-4b11-bcf0-12ef27f2e475
Other documents for Aurobindo Pharma Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.